In the healthcare industry, preventing infections is a top priority. Medical devices, such as catheters and implants, can be breeding grounds for bacteria, which can cause serious infections in patients. Swedish startup CytaCoat is developing a new technology of antibacterial coating for medical devices to prevent such infections. In this Startup Showcase, we’ll take a closer look at how CytaCoat is working to improve patient safety.
Developing Innovative Antibacterial Coating
CytaCoat is a private Swedish company located in the Karolinska Institutet Science Park AB in Solna. Founded by a group of researchers from the Karolinska Institute and the Royal Institute of Technology, CytaCoat is developing a new technology of antibacterial coating for medical devices. The company’s proprietary polymer surface exhibits a clear effect on several of the most problematic pathogenic bacteria that pose problems in healthcare today. CytaCoat is focused on transforming this innovation into a fully viable commercial product and making it available through licenses.
Fully Equipped Laboratory
CytaCoat has a fully equipped laboratory in the Karolinska Institutet Science Park, where microbiology evaluation, optimization of the CytaCoat technology, and pilot plant production can be performed. The company has also established contacts with clinical collaborators at Karolinska University Hospital Neonatal Unit and the Division of Clinical Microbiology. By collaborating with experienced consultants in regulatory, clinical research organizations, patent experts, and providers of specialist analyses, CytaCoat is working to develop a product that is effective and safe for patients.
Improving Patient Safety
Infections caused by bacteria can be life-threatening, especially for patients with weakened immune systems. Medical devices, such as catheters and implants, can be breeding grounds for bacteria, leading to serious infections in patients. CytaCoat’s innovative antibacterial coating technology has the potential to improve patient safety by preventing the growth and spread of bacteria on medical devices. By developing a product that is both effective and safe, CytaCoat is working to make a significant impact in the healthcare industry.
Conclusion
CytaCoat is a Solna-based startup that is developing a new technology of antibacterial coating for medical devices. By preventing the growth and spread of bacteria on medical devices, CytaCoat is working to improve patient safety in the healthcare industry. With a fully equipped laboratory and collaborations with clinical partners, CytaCoat is working to develop a product that is effective and safe for patients. By providing a solution to a significant problem in the healthcare industry, CytaCoat is making a positive impact on patient outcomes.
Website: http://www.cytacoat.com
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
